scispace - formally typeset
A

Aldemar Gordillo-Galeano

Researcher at National University of Colombia

Publications -  6
Citations -  304

Aldemar Gordillo-Galeano is an academic researcher from National University of Colombia. The author has contributed to research in topics: Solid lipid nanoparticle & Particle. The author has an hindex of 3, co-authored 5 publications receiving 168 citations. Previous affiliations of Aldemar Gordillo-Galeano include University of Texas at San Antonio.

Papers
More filters
Journal ArticleDOI

Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release

TL;DR: The importance of obtaining a detailed knowledge of the structure of the lipid nanoparticles is highlighted, which is useful for the rational design of this type of nanocarriers and propose solutions to the challenges involved in their formulation.
Journal ArticleDOI

Hydrodynamic diameter and zeta potential of nanostructured lipid carriers: Emphasizing some parameters for correct measurements

TL;DR: In this paper, the importance of suitable experimental conditions to estimate the hydrodynamic diameter and the surface charge of lipid nanoparticles, specifically in nanostructured lipid carriers (NLC) stabilized by nonionic surfactants, by using dynamic light scattering and laser Doppler electrophoresis, respectively, is stressed.
Journal ArticleDOI

Surface structural characteristics of some colloidal lipid systems used in pharmaceutics

TL;DR: In this paper, surface properties of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and nanoemulsions (NE) were studied with binary mixtures of trimyristin and medium-chain triglycerides (MCT) and stabilized with Poloxamer 188.
Journal ArticleDOI

Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment.

TL;DR: In this paper, the authors investigated the possibility of modifying the drug regimens to facilitate therapy adherence, avoid mycobacterium drug resistance, and minimize toxic side effects using lipid nanoparticles.